| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/12/1992 | US5112950 Factor viii analog, preparation process, and pharmaceutical composition containing it |
| 05/12/1992 | US5112946 Polypeptides and proteins with mutant segments for treatment of cardiovascular disorders and antitumor agents |
| 05/12/1992 | US5112767 Vectors with enhancer domains |
| 05/12/1992 | US5112755 DNA coding sequence expressed in Escherichia, genetic engineering |
| 05/12/1992 | US5112754 Tissue plasminogen-activating factor and nonoclonal antibody |
| 05/12/1992 | US5112753 Method of identification and preparation of probes for pestiviruses, oligonucleotides and probes thus obtained and a method of detection of pestiviruses |
| 05/12/1992 | US5112749 Recombinant DNA sequences for attenuated bacterium, Salmonella or Shigella and epitopes |
| 05/12/1992 | US5112748 Hybrid cells producing an antigen characteristic of the hepatitis b virus obtained from hepatocytes and established monkey cells, a process for obtaining these hybrid cells and their application to the production of the aforesaid antigen |
| 05/12/1992 | US5112744 Plasmids for the production of human Cu-Zn superoxide dismutase, bacterial hosts containing the plasmids and methods for production and recovery of such superoxide dismutase |
| 05/12/1992 | US5112734 Target-dependent synthesis of an artificial gene for the synthesis of a replicatable rna |
| 05/12/1992 | US5112608 Use of protease nexin-I to mediate wound healing |
| 05/12/1992 | US5112459 Apparatus and method for transfer of macromolecules |
| 05/12/1992 | CA1300533C Sterol regulatory elements |
| 05/10/1992 | WO1992008793A1 Chinese hamster ovary cell retrovirus-like c particles |
| 05/10/1992 | WO1992008791A1 Method of targeting dna |
| 05/10/1992 | WO1992008495A1 Cytokine immunoconjugates |
| 05/10/1992 | CA2095635A1 Chinese hamster ovary cell retrovirus-like c particles |
| 05/09/1992 | WO1992008736A1 Hirudine mutant, production thereof, anticoagulant, secretory vector, microorganism transformed by said vector, and production of product from said microorganism |
| 05/09/1992 | WO1992008728A1 Incorporation of multiple reporter groups on synthetic oligonucleotides |
| 05/09/1992 | CA2255396A1 Hirudin analog, method of manufacturing thereof and anti-coagulant composition, and secretion vector, transformed microorganisms containing said vector and manufacturing method ofproducts which is produced from said microorganism |
| 05/09/1992 | CA2095212A1 Incorporation of multiple reporter groups on synthetic oligonucleotides |
| 05/09/1992 | CA2055150A1 Plasmids for the production of transgenic plants that are modified in habit and yield |
| 05/09/1992 | CA2055149A1 Non-a, non-b hepatitis virus related antigen, antibody, detection systems, polynucleotides and polypeptides |
| 05/08/1992 | WO1992008456A2 Method of inhibiting transformation, growth and metastasis of cells in which purine metabolic enzyme activity is elevated |
| 05/08/1992 | CA2095732A1 Method of inhibiting transformation, growth and metastasis of cells in which purine metabolic enzyme activity is elevated |
| 05/08/1992 | CA2055145A1 Dna encoding a protein which binds to the enhancer of .alpha.-fetoprotein gene |
| 05/07/1992 | WO1992007958A1 Test for virulent revertants in attenuated live vaccines |
| 05/07/1992 | WO1992007948A1 Compositions and methods for analyzing genomic variation |
| 05/07/1992 | WO1992007579A1 Soluble mannose receptor peptides |
| 05/07/1992 | CA2095729A1 Soluble mannose receptor peptides |
| 05/07/1992 | CA2073184A1 Compositions and methods for analyzing genomic variation |
| 05/07/1992 | CA2054791A1 Method for altering post-translational processing of tissue plasminogen activator |
| 05/06/1992 | EP0484017A2 Endothelin precursors, genes and receptors |
| 05/06/1992 | EP0483961A1 Specific binding agents |
| 05/06/1992 | EP0483911A2 Chicken anemia virus vaccine and diagnostic reagent |
| 05/06/1992 | EP0483847A2 Method for preparing transformed plant |
| 05/06/1992 | EP0483797A1 Method for cloning and producing the Nco I restriction endonuclease |
| 05/06/1992 | EP0483691A2 Xyloseisomerase gene of thermus aquaticus, xyloseisomerase and process for preparation of fructose |
| 05/06/1992 | EP0483509A1 Synthetic gene coding for human parathyroid hormone |
| 05/06/1992 | EP0483351A1 Soluble single chain t cell receptors |
| 05/06/1992 | EP0483287A1 Glyphosate-tolerant 5-enolpyruvyl-3-phosphoshikimate synthases |
| 05/06/1992 | EP0483281A1 Recombinant human thyroid peroxidase |
| 05/06/1992 | EP0483269A1 RESTRICTION ENDONUCLEASE $i(Fse)I |
| 05/06/1992 | EP0483249A1 Method of transcriptionally modulating gene expression and of discovering chemicals capable of functioning as gene expression modulators |
| 05/06/1992 | EP0483247A1 Recombinantly produced human membrane cofactor protein (mcp) |
| 05/06/1992 | EP0483219A1 Enhancement of musculature in animals |
| 05/06/1992 | EP0461180A4 Development of a monoclonal antibody based detection system for listeria monocytogenes |
| 05/06/1992 | CN1060872A Spheroplast fusions of phaffia rhodozyma cells |
| 05/06/1992 | CN1060871A Novel onco-fetal gene, gene product and uses therefor |
| 05/05/1992 | US5110908 Haemophilus influenzae peptides and proteins |
| 05/05/1992 | US5110906 Derivatives of soluble T-4 |
| 05/05/1992 | US5110905 Activated Bacillus thuringienses delta-endotoxin produced by an engineered hybrid gene |
| 05/05/1992 | US5110802 Oligonucleotide phosphonates and method of inhibiting a human immunodeficiency virus in vitro utilizing said oligonucleotide phosphonates |
| 05/05/1992 | US5110738 Genetic engineering; hybridomas of melanoma and spleen cells |
| 05/05/1992 | US5110732 Selective gene expression in plants |
| 05/05/1992 | US5110731 System for biotin synthesis |
| 05/05/1992 | US5110729 Method of producing peptides using baculovirus vectors in cultured cells |
| 05/05/1992 | US5110728 Acyl carrier protein - DNA sequence and synthesis |
| 05/05/1992 | US5110588 Composite salmonella E. coli, Vibrio cholerae vaccine strains |
| 05/05/1992 | US5110587 Immunogenic composition comprising synthetically modified vaccinia virus |
| 05/05/1992 | CA1300053C Human interleukin-2 polypeptide derivative |
| 05/05/1992 | CA1300052C Episomal vector for the expression of selected dna fragments coding for optional polypeptides in mammalian cells and methods for the production thereof |
| 05/03/1992 | CA2488792A1 Antisense oligonucleotides for treatment of cancer |
| 05/01/1992 | WO1992008731A2 T-cadherin adhesion molecule |
| 05/01/1992 | CA2095115A1 T-cadherin adhesion molecule |
| 05/01/1992 | CA2054542A1 Chicken anemia virus vaccine and diagnostic |
| 04/30/1992 | WO1992007090A1 Methods for modifying and detecting the effects on the interaction of modified polypeptides and target substrates |
| 04/30/1992 | WO1992007089A1 Method and device for amplification of dna |
| 04/30/1992 | WO1992007085A1 HUMAN CELL LINE STABLY EXPRESSING 5cDNAs ENCODING PROCARCINOGEN-ACTIVATING ENZYMES |
| 04/30/1992 | WO1992007084A1 Purified cdw52-specific antibodies |
| 04/30/1992 | WO1992007083A1 Antibodies against the urokinase receptor and their use |
| 04/30/1992 | WO1992007080A1 A eukaryotic episomal dna cloning and expression vector |
| 04/30/1992 | WO1992007079A1 Transformation selection marker system adapted for penicillium |
| 04/30/1992 | WO1992007078A1 Cloned leuconostoc mesenteroides glucose-6-phosphate dehydrogenase genes and method of making same |
| 04/30/1992 | WO1992007077A1 Engineered bacteriophages and vaccines containing them |
| 04/30/1992 | WO1992007076A1 Modified human tnfalpha (tumor necrosis factor alpha) receptor |
| 04/30/1992 | WO1992007075A1 Preparation of chimaeric antibodies using the recombinant pcr strategy |
| 04/30/1992 | WO1992007074A1 Polypeptide of a growth factor receptor family, application in the diagnosis and treatment of myeloproliferative diseases |
| 04/30/1992 | WO1992007073A1 Osteogenic peptides |
| 04/30/1992 | WO1992007071A1 Methods and applications for efficient genetic suppressor elements |
| 04/30/1992 | WO1992007070A1 Transgenic rats and animal models of inflammatory disease |
| 04/30/1992 | WO1992007068A1 Amyloidin protease and uses thereof |
| 04/30/1992 | WO1992007065A1 Modified ribozymes |
| 04/30/1992 | WO1992007002A1 A collagen binding protein as well as its preparation |
| 04/30/1992 | WO1992007001A1 Hepatitis c virus antibody |
| 04/30/1992 | WO1992006990A1 Molecular clones of hiv-1 and uses thereof |
| 04/30/1992 | WO1992006989A1 Varicella-zoster virus antigen |
| 04/30/1992 | WO1992006988A1 Method for the production of catalytic rna in bacteria |
| 04/30/1992 | WO1992006715A1 Mammalian model of a malignant disorder |
| 04/30/1992 | WO1992006711A1 Blood coagulation protein antagonists and uses therefor |
| 04/30/1992 | WO1992006707A1 Methods and compositions for the treatment of cell proliferation disorders |
| 04/30/1992 | WO1992006705A1 Heparin binding mitogen with homology to epidermal growth factor (egf) |
| 04/30/1992 | WO1992006702A1 A method for transplanting cells into the brain and therapeutic uses therefor |
| 04/30/1992 | WO1992004448A3 Human mitochondrial nad(p)+-dependent malate enzyme |
| 04/30/1992 | WO1992004443A3 B cell deficient transgenic fbv/n mice |
| 04/30/1992 | DE4034036A1 Vorrichtung und verfahren zur isolierung von nukleinsaeuren aus zellsuspensionen Apparatus and method for isolating nucleic acids from cell suspensions |
| 04/30/1992 | CA2423998A1 Methods and applications for efficient genetic suppressor elements |
| 04/30/1992 | CA2094372A1 Blood coagulation protein antagonists and uses therefor |
| 04/30/1992 | CA2094045A1 Heparin binding mitogen with egf homology |
| 04/30/1992 | CA2093919A1 Hepatitis c virus antibody |